Pancreatic Cancer Cells BxPC-3 Transfection Kit
| Kit size Volume | Quantity | ||
|---|---|---|---|
| 1.5 ml CRISPR(Cat-211248) | Inquiry | Add to cart | |
| 0.5 ml(Cat-632242) | Inquiry | Add to cart | |
| 1.5 ml(Cat-632245) | Inquiry | Add to cart | |
| 8.0 ml(Cat-632249) | Inquiry | Add to cart |
Description
Product Information
Description
Not only is pancreatic cancer difficult to diagnose, but the 5-year survival rate is also very low. As one of the cancers that seriously threaten human health, preclinical research on pancreatic cancer can help researchers find new treatments. BxPC-3 is a pancreatic cancer cell line that is tumorigenic and a reliable host for in vitro transfection studies. The BxPC-3 cell line was originally established using pancreatic tissue from a sample of a 61-year-old female patient with adenocarcinoma. BxPC-3 cells have an epithelial morphology and can be a useful in vitro transfection model. In order to facilitate in-depth research, a specific and efficient cell transfection system is essential. To this end, CD BioSciences has developed a specific transfection kit for the BxPC-3 cell line.
